Approvals/TGA/EVOCAIR MDI 250/25 fluticasone propionate 250 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter)

Approved

STANDARD

EVOCAIR MDI 250/25 fluticasone propionate 250 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter)

Alphapharm Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 5d4c542eac8f96ab
Company: Alphapharm Pty Ltd
Type: Standard

Approval Details

Approval Id: 5d4c542eac8f96ab
Product Name: EVOCAIR MDI 250/25 fluticasone propionate 250 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter)
Artg Id: 208668
Artg Name: EVOCAIR MDI 250/25 fluticasone propionate 250 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter)
Sponsor: Alphapharm Pty Ltd
Company Detail Path: /organization/alphapharm-pty-ltd
Artg Date: 2014-05-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/60cc8a55397f3be6247cc69e0ad051a9.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/751c8d658407dced98387446f4e6cf18.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

5d4c542eac8f96ab

Type

Standard

Back to TGA Approvals